Contraception Flashcards
32yo F on OCPs for 3 months, BP elevated. Most appropriate next step?
Discontinue OCPs and recommend barrier method
Both estrogen and progesterone are known to cause BP elevation
Most commonly sited as the reason for discontinuing OCPs?
Irregular bleeding
Nausea, breast tenderness, fluid retention are also common SE
Risk associated w/ OCP use?
Increased risk of VTE
They are protective of Ovarian and Endometrial cancers
Pt forgets to take regular dose of OCPs and had intercourse. Next step?
Use emergency contraception immediately and restart her pills the following day
If an active pill is missed at any time, and no intercourse has occurred in the past 5 days, two pills should be taken immediately and a backup method should be used for 7 days.
If intercourse occurred in the previous 5 days, emergency contraception should be used immediately and pills should be restarted the following day. A backup method should be used for 5 days.
29yo obese F w/ T2DM asks about progestin only pills. What about them?
Have to take everyday
Prevents contraception via:
- thickening of cervical mucous
- suppression of ovulation
- alteration of endometrium
- inhibition of tubal transport
36yo F smokes one pack per day, 145lbs, no other health concerns. Not in monogamous relationship. What is best method of contraception?
Injectable form of long-acting progestin
OCPs, intravaginal ring, transdermal patch are contraindicated in smokers >35yo
IUDs increase risk for STI and PID
How are emergency contraception pills (ECP) used?
Within 72 hours, when no contraception was used (sexual assault) or contraceptive failure.
No medical contraindication
Does not disrupt already implanted pregnancy
Does not cause birth defects
Child w/ multiple malformations of unknown etiology. What type of testing would be best for identifying the dx?
Cytogenetic analysis (trisomies)
Direct DNA testing (already know gene, i.e., CF) Biochemical tests (identify or quantify metabolites or enzymes, metabolism d/o) Linkage analysis (identify genetic sequences that are physically in close proximity to a disease gene of interest)